GSK Invention definition

GSK Invention means an Invention that is invented by an employee or agent of GSK solely or jointly with a Third Party.
GSK Invention shall have the meaning set forth in Section 9.3.2.
GSK Invention means both (i) any Invention that has been discovered, made, conceived and first reduced to practice prior to the COVID First Amendment Effective Date and has been notified by the inventing Party to the other Party at the latest [*****] after the COVID First Amendment Effective Date, and which qualifies as a “GSK Invention” pursuant to the version of this Agreement in effect prior to the COVID First Amendment Effective Date; and (ii) any later Invention that falls under the definition of “GSK Invention” as set forth in Section 9.3.1 (ii) of this COVID First Amendment. ​

Examples of GSK Invention in a sentence

  • If CureVac notifies GSK within the above [*****] deadline that CureVac decides to file an application for a CureVac Invention, the Parties shall coordinate the filing of the application for a GSK Invention with the filing of CureVac’s application for such CureVac Invention so that CureVac’s application and GSK’s application are filed on the same day or otherwise filed in a way that secures and protects each of the Parties’ interest.

  • GSK shall have the sole right, but not the obligation, at its sole expense, to file, prosecute, maintain and defend the Patent Rights Covering a GSK Invention (each, a “GSK Program Patent Right”) throughout the Territory in good faith consistent with its customary patent policy and its reasonable business judgment and shall consider in good faith the reasonable interests of CureVac in so doing.

  • Notwithstanding the above, prior to filing any application for a GSK Invention that may disclose, in part or in full, a CureVac Invention, Joint Product Invention or Joint Other Invention, GSK shall provide CureVac with a copy of the draft application and provide CureVac with at least [*****] to review and comment upon the text of such draft application.

  • Notwithstanding the above, prior to filing any application for a CureVac Invention that may disclose, in part or in full, a GSK Invention, a Joint Product Invention or Joint Other Invention, CureVac shall provide GSK with a copy of the draft application and provide GSK with at least [*****] to review and comment upon the text of such draft application.

  • For the avoidance of doubt, CureVac will not include a GSK Invention, Joint Product Invention or Joint Other Invention in a separate patent claim of a patent application to be filed by CureVac without GSK’s prior written consent.


More Definitions of GSK Invention

GSK Invention shall have the meaning provided in Section 7.2.
GSK Invention is defined in Section 16.1.
GSK Invention means any Invention made solely by one or more employees, officers, directors, consultants or contractors of GSK.
GSK Invention means any invention or discovery (a) which is conceived or reduced to practice by or on behalf of GSK, its Affiliates or Third Party Sublicensees at any time up to the [**] anniversary of the [**] hereof as a result of the practice of the Licensed Patent Rights or the use of QS-21 pursuant to this Agreement, the Supply Agreement, and/or the Prior Agreement and (b) in so far as it is related to QS-21 and in so far as it is not related to (i) [**], (ii) [**], (iii) [**] and/or (iv) any other [**], and (c) that would block the making, using, or selling of QS-21 in Antigenics MA’s or its Affiliates’ [**] based [**].
GSK Invention has the meaning set forth in Section 17.2. 1.57 “GSK IPR” has the meaning set forth in Section 17.2. 1.58 “GSK Regulatory Documentation” means any Regulatory Documentation pertaining to the GSK BCMA Product that exists as of the Original Effective Date or that is created other than in connection with this Agreement. For the avoidance of doubt, GSK Regulatory Documentation does not include Study Regulatory Documentation. 1.59 “GSK-Related Compound” has the meaning set forth in Section 16.3. 1.60 “HIPAA” has the meaning set forth in the definition of Data Protection Law. 1.61 “IND” means the Investigational New Drug Application filed or to be filed with the FDA as described in Title 21 of the U.S. Code of Federal Regulations, Part 312, and the equivalent application in the jurisdictions outside the United States, including an “Investigational Medicinal Product Dossier” filed or to be filed with the EMA. 1.62 “Initiation” means, with respect to a Clinical Study, the dosing of the first patient in such Clinical Study. 1.63 “Intellectual Property Rights” means all patents, inventions (whether patentable or not), discoveries, rights in confidential information, Know-How and trade secrets (and any documents containing such confidential information, Know-How or trade secrets), trademarks and service marks, copyrights (including in computer software) (in each case whether registered or not), registered designs, design rights, contractual waivers of moral rights, rights in databases and collections of data, utility models and all similar property rights whether or not registered or registrable, designs, drawings, performances, computer
GSK Invention shall have the meaning set forth in Section 5.
GSK Invention means any invention made during the Term of this Agreement as a result of the performance of the Evaluation Program [*]; and “Biomarker Invention” means any invention made during the Term of this Agreement as a result of the performance by ACLARA of the Evaluation Program [*].